ArticleHepatobiliary surgery and nutrition2025

Do Asian patients with HCC derive greater benefit from anti-PD-L1 plus anti-CTLA-4 therapy?

Atsushi Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.